American Society of Hirudotherapy

Direction de la Pharmacie et du Médicament — République du Mali

Mali DPM · Mali · africa

Regulatory jurisdiction profileJurisdictional reference
Unregulatednational regulator

Mali's pharmacy / medicine directorate — leech-specific authorisation pathway not independently verified by ASH.

Regulatory Profile

Agency type
national regulator
Region
africa
Country
Mali
Leech status
unregulated
Last ASH review
2026-05-28

Relevant Regulation Codes

  • Mali Code de Santé Publique and amendments
  • ECOWAS Pharmaceutical Regulatory Harmonisation arrangements where applicable

Prescriber Requirements

  • Mali Ordre des Médecins–registered physician — order required for any biomedical device application
  • Allied health professional application under physician supervision per institutional protocol

Supply Chain & GMP

Mali DPM registration as applicable; French-language labelling. Standard cold-chain conditions with logistical constraints typical of Sahel distribution.

Import/Export Rules

Mali DPM and Direction Nationale des Services Vétérinaires clearance for live invertebrates; CITES Appendix II paperwork for Hirudo medicinalis / verbana.

Reimbursement Context

Mali AMO (Assurance Maladie Obligatoire) coverage depends on inpatient bundling; outpatient hirudotherapy is generally not separately reimbursed.

ASH Editorial Notes

Leech-specific authorisation pathway not independently verified by ASH; falls under general medical-device / traditional-medicine framework as appropriate. ECOWAS West-African regulatory harmonisation arrangements have not been independently mapped by ASH for live-organism medical devices.

Related Jurisdictions

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.